Close Menu

codevelopment agreement

NEW YORK (GenomeWeb) – Advanced Cell Diagnostics announced today a preferred partnership agreement with Dundee, UK-based MicroMatrices to develop applications of its RNAscope technology.

NEW YORK (GenomeWeb) – Qiagen announced after the close of the market Tuesday that it has signed a master collaboration agreement to develop and commercialize companion diagnostics to pair with drugs being developed by Astellas Pharma for cancer and other diseases.

NEW YORK (GenomeWeb) – Eureka Genomics and VeriPrime Beef Cooperative today announced a deal to develop molecular assays to better manage cattle health risk.

NEW YORK (GenomeWeb) – The Jackson Laboratory and Boston's Beth Israel Deaconess Medical Center have partnered to launch clinical genomics initiatives targeting new diagnostics and treatments and collaborative genomic education programs, Jackson Lab said on Monday.

NEW YORK (GenomeWeb) – Molecular diagnostics firm OvaGene announced on Thursday an R&D collaboration with Hitachi Chemical Research Center to develop novel mRNA-based signatures for gynecological cancers.

NEW YORK (GenomeWeb) — South Korean molecular diagnostics firm Bioneer announced on Wednesday the availability of a molecular test kit for the Ebola virus that it has developed in collaboration with the Nigerian National Biotechnology Development Agency (NABDA).

NEW YORK (GenomeWeb) – Lucigen announced yesterday that it has partnered with Thermo Fisher Scientific to develop and launch a long mate pair library kit for the Ion Torrent Personal Genome Machine sequencing platform.

NEW YORK (GenomeWeb) — Illumina has partnered with AstraZeneca, Janssen Biotech, and Sanofi to develop a universal next-generation sequencing-based oncology test system for multi-analyte companion diagnostics, the company said today.

NEW YORK (GenomeWeb) – Roche will collaborate with the Garvan Institute of Medical Research in Sydney to develop technology for targeted next-gen sequencing-based epigenomic analysis, the company said today.

NEW YORK (GenomeWeb) – TTFactor — the technology transfer firm of the European Institute of Oncology and the FIRC Institute of Molecular Oncology — investment firm BioVitas Capital, and the University of Milan today announced two deals to develop genomic biomarkers for lung, breast, and ovarian c

Pages

The Wall Street Journal looks into FamilyTreeDNA's handling of genetic genealogy searches by law enforcement.

In a point-counterpoint in the Boston Globe, researchers discuss the potential of gene editing to prevent Lyme disease, but also the pitfalls of doing so.

MIT's Technology Review reports that researchers hope to develop a CRISPR-based pain therapy.

In Science this week: atlas of malaria parasites' gene expression across their life cycles, and more.